ANGELA COLLIER: Open Payments
NPI 1558911776 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 35 payments from 11 companies in 2025. Trend: 2023 $629 · 2024 $134 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $260 |
| Amgen Inc. | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Novo Nordisk Inc | 4 | $74 |
| Verona Pharma, Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Viatris Specialty LLC | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: VRAYLAR, OTEZLA, FARXIGA, Ohtuvayre, Cologuard Collection Kit, QULIPTA, Rybelsus, XIFAXAN.
Industry payments across VA — which companies pay providers there.
